Clifford Chance acted for Brookfield as anchor investor. Lanza Capital (formerly known as Firmum Capital) has raised €550m for its second fund focused on car park opportunities....
LanzaCapital’s €550 Million Financing Round
Fresenius’ Sell Its 70% Stake in Hospital Market in Peru
Clifford Chance advised healthcare group Fresenius and its Spanish subsidiary QuironSalud on the deal. Fresenius sells its 70% stake in IDCQ CRP, a co-holding entity of...
Keensight Capital’s Acquisition of Inke
Clifford Chance has advised Neuraxpharm on the deal. Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announced...
Permira’s Acquisition of Neuraxpharm
Clifford Chance advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical...
China Three Gorges Spain’s Acquisition of a 619MW Renewables Portfolio in Spain from Nexwell Power
Clifford Chance has advised China Three Gorges Spain on the deal. China Three Gorges Spain (CTGS) agreed to acquire a 619MW portfolio of photovoltaic projects in...